Olgu Sunumu
BibTex RIS Kaynak Göster

Refractory status epilepticus responding to lidocaine: a case report

Yıl 2018, Cilt: 4 Sayı: 3, 254 - 257, 04.07.2018
https://doi.org/10.18621/eurj.361883

Öz

Status epilepticus is a life-threatening condition, which is associated
with a high mortality and morbidity when left untreated. It is
defined as a continuous seizure lasting more than 30 min or successive seizures
with no recovery between any of them
. Mortality of status epilepticus
depends on the duration and type of seizure, concomitant diseases and age of
the patient. Managament of status epilepticus includes ensuring adequate
airway, stabilization of circulation and use of antiepileptic drugs.
Benzodiazepines, phenobarbital, phenytoin, fosphenytoin, general anesthesia and
lidocaine are used for the treatment of status epilepticus. Here, we discuss a
patient with refractory status epilepticus who achieved a very good response
and full recovery only with lidocain infusion among all forms of therapy given. 

Kaynakça

  • [1] Canas N, Delgado H, Silva V, Pinto AR, Sousa S, Simões R, et al. The electroclinical spectrum, etiologies, treatment and outcome of nonconvulsive status epilepticus in the elderly. Epilepsy Behav 2017;79:53-7.
  • [2] Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012;17:3-23.
  • [3] Towne AR, Pellock JM, Ko D, DeLorenzo RJ. Determinants of mortality in status epilepticus. Epilepsia 1994;35:27-34.
  • [4] DeLorenzo RJ, Ko D, Towne AR, Garnett LK, Boggs JG, Waterhouse EJ, et al. Prediction of outcome in status epilepticus. Epilepsia 1997;38(suppl 8):210-5.
  • [5] Riviello JJ Jr, Claassen J, LaRoche SM, Sperling MR, Alldredge B, Bleck TP, et al. Treatment of status epilepticus: an international survey of experts. Neurocrit Care 2013;18:193-200.
  • [6] Lempl Y, Eshel Y, Gilad R, Sarova-Pinchas I. Chloral hydrate in intractable status epilepticus. Ann Emerg Med 1990;19:674-6.
  • [7] Knake S, Gruener J, Hattemer K, Klein KM, Bauer S, Oertel WH, et al Intravenous levetiracetam in the treatment of benzodiazepine-refractory status epilepticus. J Neurol Neurosurg Psychiatry 2008;79:588-9.
  • [8] Agarwal P, Kumar N, Chandra R, Gupta G, Antony AR, Garg N. Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure 2007;16:527-32.
  • [9] Mori K, Ito H, Toda Y, Hashimoto T, Miyazaki M, Saijo T, et al. Successful management of intractable epilepsy with lidocaine tapes and continuous subcutaneous lidocaine infusion. Epilepsia 2004;45:1287-90.
Yıl 2018, Cilt: 4 Sayı: 3, 254 - 257, 04.07.2018
https://doi.org/10.18621/eurj.361883

Öz

Kaynakça

  • [1] Canas N, Delgado H, Silva V, Pinto AR, Sousa S, Simões R, et al. The electroclinical spectrum, etiologies, treatment and outcome of nonconvulsive status epilepticus in the elderly. Epilepsy Behav 2017;79:53-7.
  • [2] Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012;17:3-23.
  • [3] Towne AR, Pellock JM, Ko D, DeLorenzo RJ. Determinants of mortality in status epilepticus. Epilepsia 1994;35:27-34.
  • [4] DeLorenzo RJ, Ko D, Towne AR, Garnett LK, Boggs JG, Waterhouse EJ, et al. Prediction of outcome in status epilepticus. Epilepsia 1997;38(suppl 8):210-5.
  • [5] Riviello JJ Jr, Claassen J, LaRoche SM, Sperling MR, Alldredge B, Bleck TP, et al. Treatment of status epilepticus: an international survey of experts. Neurocrit Care 2013;18:193-200.
  • [6] Lempl Y, Eshel Y, Gilad R, Sarova-Pinchas I. Chloral hydrate in intractable status epilepticus. Ann Emerg Med 1990;19:674-6.
  • [7] Knake S, Gruener J, Hattemer K, Klein KM, Bauer S, Oertel WH, et al Intravenous levetiracetam in the treatment of benzodiazepine-refractory status epilepticus. J Neurol Neurosurg Psychiatry 2008;79:588-9.
  • [8] Agarwal P, Kumar N, Chandra R, Gupta G, Antony AR, Garg N. Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure 2007;16:527-32.
  • [9] Mori K, Ito H, Toda Y, Hashimoto T, Miyazaki M, Saijo T, et al. Successful management of intractable epilepsy with lidocaine tapes and continuous subcutaneous lidocaine infusion. Epilepsia 2004;45:1287-90.
Toplam 9 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Case Report
Yazarlar

Gökhan Özer 0000-0003-0039-2350

Yayımlanma Tarihi 4 Temmuz 2018
Gönderilme Tarihi 5 Aralık 2017
Kabul Tarihi 22 Aralık 2017
Yayımlandığı Sayı Yıl 2018 Cilt: 4 Sayı: 3

Kaynak Göster

AMA Özer G. Refractory status epilepticus responding to lidocaine: a case report. Eur Res J. Temmuz 2018;4(3):254-257. doi:10.18621/eurj.361883

e-ISSN: 2149-3189 


The European Research Journal, hosted by Turkish JournalPark ACADEMIC, is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

by-nc-nd.png

2024